Vol 1, No 3 (2009)
Mol Cell Pharmacol
Table of Contents
PharmSights
| PUMA Kills Stem Cells to Stall Cancer? | Abstract PDF |
| Jian Yu | 112-118 |
| Transgenic Humanized AHR Mouse Reveals Differences between Human and Mouse AHR Ligand Selectivity | Abstract PDF |
| Colin A. Flaveny, Gary H. Perdew | 119-123 |
| Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway | Abstract PDF |
| Ling-Hui Zeng, Nicholas R. Rensing, Michael Wong | 124-129 |
Research Articles
| Nucleolin Binds to the Proliferating Cell Nuclear Antigen and Inhibits Nucleotide Excision Repair | Abstract PDF |
| Chonglin Yang, Myoung Sook Kim, Devulapalli Chakravarty, Fred E. Indig, France Carrier | 130-137 |
| Extraction, Characterization, Stability and Biological Activity of Flavonoids Isolated from Chamomile Flowers | Abstract PDF |
| Janmejai K. Srivastava, Sanjay Gupta | 138-147 |
Reviews
| RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking | Abstract PDF |
| Ki Lui, Ying Huang | 148-156 |
| The Regulation of YY1 in Tumorigenesis and its Targeting Potential in Cancer Therapy | Abstract PDF |
| Guangchao Sui | 157-176 |
FDA Corner
| FDA Approves New Drug Treatment for Type 2 Diabetes | Abstract PDF |
| 177 |
| FDA Approves First Maintenance Drug Therapy for Advanced Lung Cancer | Abstract PDF |
| 177 |
| FDA Approves Multaq to Treat Heart Rhythm Disorder | Abstract PDF |
| 178 |
| FDA Approves Drug for Treatment of Aggressive Brain Cancer | Abstract PDF |
| 178-179 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.